Replies to post #231860 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

Where is the "and fund part".....?????????

Under the terms of the agreement, the initial trial will be conducted (organize and carry out) by Peregrine.

Astra Zeneca doc used the term "partner"

You lose...NEXT

Why did you pick the moniker Tarvacin in 2006? A little before your time no?

wook

[JJ1223]

It does not appear that your quote establishes who will pay for what costs, unless you believe Iannone was saying future benefits of the collaboration would only be for the benefit of Penegrine.
Only then would your quote indicate Peregrine would pay all costs, but that is doubtful.

Under your theory, you must also believe MSK is paying all costs associated with any trials with Bavituximab.

Robert Iannone, Head of Immuno-Oncology, Global Medicines Development, at AstraZeneca said, "We believe that combination therapy in immuno-oncology has the potential to be a novel and highly effective approach to treating cancer. Our partnership with Peregrine provides the opportunity to explore an exciting, novel combination that could deliver important clinical benefit to patients across a range of cancers." [/quote]